144 related articles for article (PubMed ID: 33476737)
1. Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer.
Rahimi A; Morgan HE; Kim DW; Zhang Y; Leitch M; Wooldridge R; Goudreau S; Haley B; Rao R; Rivers A; Spangler AE; Jones RT; Stevenson S; Staley J; Albuquerque K; Ahn C; Neufeld S; Alluri PG; Ding C; Garwood D; Seiler S; Zhao B; Gu X; Timmerman R
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):772-782. PubMed ID: 33476737
[TBL] [Abstract][Full Text] [Related]
2. Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation.
Rahimi A; Thomas K; Spangler A; Rao R; Leitch M; Wooldridge R; Rivers A; Seiler S; Albuquerque K; Stevenson S; Goudreau S; Garwood D; Haley B; Euhus D; Heinzerling J; Ding C; Gao A; Ahn C; Timmerman R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):196-205.e2. PubMed ID: 28586960
[TBL] [Abstract][Full Text] [Related]
3. Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer.
Rahimi A; Simmons A; Kim DN; Leitch M; Haas J; Gu X; Ahn C; Gao A; Spangler A; Morgan HE; Goudreau S; Seiler S; Farr D; Wooldridge R; Haley B; Bahrami S; Neufeld S; Mendez C; Alluri P; Rao R; Timmerman RD
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):663-670. PubMed ID: 34710523
[TBL] [Abstract][Full Text] [Related]
4. Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes.
Bush DA; Do S; Lum S; Garberoglio C; Mirshahidi H; Patyal B; Grove R; Slater JD
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):501-5. PubMed ID: 25084608
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing cosmetic results after conservation therapy for breast cancer.
Taylor ME; Perez CA; Halverson KJ; Kuske RR; Philpott GW; Garcia DM; Mortimer JE; Myerson RJ; Radford D; Rush C
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):753-64. PubMed ID: 7860386
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical Trial.
Rahimi A; Zhang Y; Kim DW; Morgan H; Hossain F; Leitch M; Wooldridge R; Seiler S; Goudreau S; Haley B; Rao R; Rivers A; Spangler A; Ahn C; Stevenson S; Staley J; Albuquerque K; Ding C; Gu X; Zhao B; Timmerman R
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):697-706. PubMed ID: 32464155
[TBL] [Abstract][Full Text] [Related]
7. Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial.
Merie R; Browne L; Cardoso JS; Cardoso MJ; Chin Y; Clark C; Graham P; Szwajcer A; Hau E
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):819-825. PubMed ID: 28834326
[TBL] [Abstract][Full Text] [Related]
8. Single-Institution Phase 1/2 Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial-Breast Irradiation for Hormone Sensitive Stage 0-I Breast Cancer.
Kennedy WR; Thomas MA; Stanley JA; Luo J; Ochoa LL; Clifton KK; Cyr AE; Margenthaler JA; DeWees TA; Price A; Kashani R; Green O; Zoberi I
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):344-352. PubMed ID: 32084524
[TBL] [Abstract][Full Text] [Related]
9. Impact of radiation treatment parameters and adjuvant systemic therapy on cosmetic outcomes after accelerated partial breast irradiation using 3-dimensional conformal radiation therapy technique.
Mellon EA; Sreeraman R; Gebhardt BJ; Mierzejewski A; Correa CR
Pract Radiat Oncol; 2014; 4(3):e159-e166. PubMed ID: 24766690
[TBL] [Abstract][Full Text] [Related]
10. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
[TBL] [Abstract][Full Text] [Related]
11. Excellent Long-term Breast Preservation Rate After Accelerated Partial Breast Irradiation Using a Balloon Device.
Mann JM; Osian AD; Brandmaier A; Yan W; Sung KJ; Siegel B; Fink S; Kaplan B; Fulman M; Wu G; Christos P; Nori D; Ravi A
Clin Breast Cancer; 2016 Jun; 16(3):217-22. PubMed ID: 26948247
[TBL] [Abstract][Full Text] [Related]
12. Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience.
Keller LM; Sopka DM; Li T; Klayton T; Li J; Anderson PR; Bleicher RJ; Sigurdson ER; Freedman GM
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):881-7. PubMed ID: 22909414
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer.
Pinnarò P; Arcangeli S; Giordano C; Arcangeli G; Impiombato FA; Pinzi V; Iaccarino G; Soriani A; Landoni V; Strigari L
Radiat Oncol; 2011 Nov; 6():155. PubMed ID: 22079051
[TBL] [Abstract][Full Text] [Related]
14. Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
Vrieling C; Collette L; Bartelink E; Borger JH; Brenninkmeyer SJ; Horiot JC; Pierart M; Poortmans PM; Struikmans H; Van der Schueren E; Van Dongen JA; Van Limbergen E; Bartelink H
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):667-76. PubMed ID: 10524421
[TBL] [Abstract][Full Text] [Related]
15. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
16. Toxicity and cosmesis following partial breast irradiation consisting of 40 Gy in 10 daily fractions.
Trovo M; Roncadin M; Polesel J; Piccoli E; Mileto M; Micheli E; Perin T; Carbone A; Massarut S; Trovo MG
Breast; 2013 Oct; 22(5):744-7. PubMed ID: 23352319
[TBL] [Abstract][Full Text] [Related]
17. International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
Olivotto IA; Link E; Phillips C; Whelan TJ; Bryant G; Kunkler IH; Westenberg AH; Purohit K; Ahern V; Graham PH; Akra M; McArdle O; Ludbrook JJ; Harvey JA; Maduro JH; Kirkove C; Gruber G; Martin JD; Campbell ID; Delaney GP; Chua BH;
Radiother Oncol; 2020 Jan; 142():180-185. PubMed ID: 31431385
[TBL] [Abstract][Full Text] [Related]
18. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.
Vicini FA; Beitsch PD; Quiet CA; Keleher A; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer H; Whitacre EB; Whitworth PW; Fine RE; Haffty BG; Arrambide LS
Cancer; 2005 Sep; 104(6):1138-48. PubMed ID: 16088962
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy.
Vicini FA; Keisch M; Shah C; Goyal S; Khan AJ; Beitsch PD; Lyden M; Haffty BG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):512-8. PubMed ID: 22079730
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Study of Cosmetic Outcomes for Patients Treated with Breast Conservation and Radiation Therapy using Shorter Fractionation Schedules at Auckland Hospital, New Zealand.
Campbell G; Pearse M; Frampton C
Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):221-227. PubMed ID: 31740191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
